Skip to main content
. 2010 Jun 17;10:29. doi: 10.1186/1471-2261-10-29

Figure 3.

Figure 3

Kaplan-Meier analysis of days to CV event in SPAA and CCB/statin primary prevention patients with no history of cancer or chronic renal failure